8824 related articles for article (PubMed ID: 18951451)
41. Audit of catheter-associated UTI using silver alloy-coated Foley catheters.
Seymour C
Br J Nurs; 2006 Jun 8-21; 15(11):598-603. PubMed ID: 16835528
[TBL] [Abstract][Full Text] [Related]
42. A pilot randomized double-blind placebo-controlled trial on the use of antibiotics on urinary catheter removal to reduce the rate of urinary tract infection: the pitfalls of ciprofloxacin.
Wazait HD; Patel HR; van der Meulen JH; Ghei M; Al-Buheissi S; Kelsey M; Miller RA; Emberton M
BJU Int; 2004 Nov; 94(7):1048-50. PubMed ID: 15541126
[TBL] [Abstract][Full Text] [Related]
43. Catheter associated urinary tract infections in neurology and neurosurgical units.
Puri J; Mishra B; Mal A; Murthy NS; Thakur A; Dogra V; Singh D
J Infect; 2002 Apr; 44(3):171-5. PubMed ID: 12099744
[TBL] [Abstract][Full Text] [Related]
44. Urinary tract infections.
Chenoweth CE; Saint S
Infect Dis Clin North Am; 2011 Mar; 25(1):103-15. PubMed ID: 21315996
[TBL] [Abstract][Full Text] [Related]
45. Decreased urethral mucosal damage and delayed bacterial colonization during short-term urethral catheterization using a novel trefoil urethral catheter profile in rabbits.
Sun Y; Zeng Q; Zhang Z; Xu C; Wang Y; He J
J Urol; 2011 Oct; 186(4):1497-501. PubMed ID: 21855927
[TBL] [Abstract][Full Text] [Related]
46. Inappropriate treatment of catheter-associated asymptomatic bacteriuria in a tertiary care hospital.
Cope M; Cevallos ME; Cadle RM; Darouiche RO; Musher DM; Trautner BW
Clin Infect Dis; 2009 May; 48(9):1182-8. PubMed ID: 19292664
[TBL] [Abstract][Full Text] [Related]
47. Catheter-associated urinary tract infection.
Danchaivijitr S; Dhiraputra C; Cherdrungsi R; Jintanothaitavorn D; Srihapol N
J Med Assoc Thai; 2005 Dec; 88 Suppl 10():S26-30. PubMed ID: 16850636
[TBL] [Abstract][Full Text] [Related]
48. Comparison of Oligon catheters and chlorhexidine-impregnated sponges with standard multilumen central venous catheters for prevention of associated colonization and infections in intensive care unit patients: a multicenter, randomized, controlled study.
Arvaniti K; Lathyris D; Clouva-Molyvdas P; Haidich AB; Mouloudi E; Synnefaki E; Koulourida V; Georgopoulos D; Gerogianni N; Nakos G; Matamis D;
Crit Care Med; 2012 Feb; 40(2):420-9. PubMed ID: 21926583
[TBL] [Abstract][Full Text] [Related]
49. Reducing the risk of catheter-related urinary tract infection.
Nazarko L
Br J Nurs; 2008 Sep 11-24; 17(16):1002, 1004, 1006 passim. PubMed ID: 19062452
[TBL] [Abstract][Full Text] [Related]
50. Comparison of silver-impregnated with standard multi-lumen central venous catheters in critically ill patients.
Kalfon P; de Vaumas C; Samba D; Boulet E; Lefrant JY; Eyraud D; Lherm T; Santoli F; Naija W; Riou B
Crit Care Med; 2007 Apr; 35(4):1032-9. PubMed ID: 17334256
[TBL] [Abstract][Full Text] [Related]
51. Intermittent catheterisation with hydrophilic-coated catheters (SpeediCath) reduces the risk of clinical urinary tract infection in spinal cord injured patients: a prospective randomised parallel comparative trial.
De Ridder DJ; Everaert K; Fernández LG; Valero JV; Durán AB; Abrisqueta ML; Ventura MG; Sotillo AR
Eur Urol; 2005 Dec; 48(6):991-5. PubMed ID: 16137822
[TBL] [Abstract][Full Text] [Related]
52. Catheter-associated urinary tract infections and other infections in patients hospitalized for acute stroke: A prospective cohort study of two different silicone catheters.
Stenzelius K; Laszlo L; Madeja M; Pessah-Rasmusson H; Grabe M
Scand J Urol; 2016 Dec; 50(6):483-488. PubMed ID: 27328334
[TBL] [Abstract][Full Text] [Related]
53. Assessment of nosocomial urinary tract infections in orthopaedic patients: a prospective and comparative study using two different catheters.
Al-Habdan I; Sadat-Ali M; Corea JR; Al-Othman A; Kamal BA; Shriyan DS
Int Surg; 2003; 88(3):152-4. PubMed ID: 14584770
[TBL] [Abstract][Full Text] [Related]
54. A prospective trial of a novel, silicone-based, silver-coated foley catheter for the prevention of nosocomial urinary tract infections.
Srinivasan A; Karchmer T; Richards A; Song X; Perl TM
Infect Control Hosp Epidemiol; 2006 Jan; 27(1):38-43. PubMed ID: 16418985
[TBL] [Abstract][Full Text] [Related]
55. Effectiveness of different central venous catheters for catheter-related infections: a network meta-analysis.
Wang H; Huang T; Jing J; Jin J; Wang P; Yang M; Cui W; Zheng Y; Shen H
J Hosp Infect; 2010 Sep; 76(1):1-11. PubMed ID: 20638155
[TBL] [Abstract][Full Text] [Related]
56. The use of rifampicin-miconazole-impregnated catheters reduces the incidence of femoral and jugular catheter-related bacteremia.
Lorente L; Lecuona M; Ramos MJ; Jiménez A; Mora ML; Sierra A
Clin Infect Dis; 2008 Nov; 47(9):1171-5. PubMed ID: 18808356
[TBL] [Abstract][Full Text] [Related]
57. A prospective, randomized trial of rifampicin-minocycline-coated and silver-platinum-carbon-impregnated central venous catheters.
Fraenkel D; Rickard C; Thomas P; Faoagali J; George N; Ware R
Crit Care Med; 2006 Mar; 34(3):668-75. PubMed ID: 16505651
[TBL] [Abstract][Full Text] [Related]
58. Reducing use of indwelling urinary catheters and associated urinary tract infections.
Elpern EH; Killeen K; Ketchem A; Wiley A; Patel G; Lateef O
Am J Crit Care; 2009 Nov; 18(6):535-41; quiz 542. PubMed ID: 19880955
[TBL] [Abstract][Full Text] [Related]
59. Can silver alloy catheters reduce infection rates?
Beattie M
Nurs Times; 2011 Jul 26-Aug 1; 107(29):19-20, 22. PubMed ID: 21941730
[TBL] [Abstract][Full Text] [Related]
60. The effectiveness of chlorhexidine-silver sulfadiazine impregnated central venous catheters in patients receiving high-dose chemotherapy followed by peripheral stem cell transplantation.
Maaskant JM; De Boer JP; Dalesio O; Holtkamp MJ; Lucas C
Eur J Cancer Care (Engl); 2009 Sep; 18(5):477-82. PubMed ID: 19453696
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
